RecruitingNCT06264583

HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV Coinfection

Studying Hepatitis delta

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Bonn
Principal Investigator
Jürgen Rockstroh, MD, M.D
University Hospital, Bonn
Intervention
HDV screening(other)
Enrollment
8000 target
Eligibility
18 years · All sexes
Timeline
2024 – 2025

Study locations (1)

Collaborators

Swiss HIV Cohort Study · ICONA Cohort · Amsterdam UMC · Royal Free Hospital NHS Foundation Trust · King's College London · University Hospital of Cologne · Goethe University · Heinrich-Heine University, Duesseldorf · University Hospital, Essen · ICH Hamburg · Praxiszentrum Hohenstaufenring Köln · Sorbonne University · Henri Mondor University Hospital · Hospital Universitario Infanta Leonor · Hospital General Universitario Gregorio Marañon · GEPCOI (Portuguese Group of Coinfection)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06264583 on ClinicalTrials.gov

Other trials for Hepatitis delta

Additional recruiting or active studies for the same condition.

See all trials for Hepatitis delta →

← Back to all trials